OGEN ORAGENICS INC

$0.59 -3.44%

Healthcare · Pharmaceutical Preparations

ORAGENICS INC (OGEN) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $3 million. Shares last traded at $0.59, 95.9% below their 52-week high. Over the past year the stock is down 86.6%. Net profit margin is -2613998.9%, below the peer median of -0.1%. Revenue declined 71.4% year over year.

Market Cap

$3M

Shares Out

4.5M

EPS (TTM)

$-15.94

P/E Ratio

—

P/S Ratio

70.70

P/B Ratio

0.43

Dividend / Share

—

Dividend Yield

—

52-Week High

$14.44

52-Week Low

$0.51

Volume

995

Avg Vol (3m)

1,576.429

Performance

-2.11%

+3.31%

-21.97%

-28.92%

YTD

-27.17%

-86.59%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

44.26

SMA (50)

$0.62

SMA (200)

$0.88

Price vs SMA50

-4.51%

Price vs SMA200

-32.87%

ATR (14)

$0.02

Financials

Revenue

$0M

Net Income

$-984M

Gross Margin

0.0%

Operating Margin

-24865.2%

Net Margin

-2613998.9%

Return on Equity

-15921.8%

Return on Assets

-13141.5%

Current Ratio

4.17

Debt / Equity

0.21

Revenue Growth (YoY)

-71.4%

Latest reported annual period ending 2023-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.51	2026-05-08
FY 2025	$-4.56	2026-03-16
Q3 2025	$-5.16	2025-11-07
Q2 2025	$-6.62	2025-08-08
Q1 2026	$-3.65	2026-05-08
FY 2025	$-47.88	2026-03-16

Full earnings history →

Pharmaceutical Preparations peers

OGEN vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/S vs peers

70.70 / 3.54 med

+1898% premium

Net margin vs peers

-2613998.9% / -0.1% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.